136 related articles for article (PubMed ID: 30371594)
1. Dual-Phase 18F-FP-CIT PET in Corticobasal Syndrome.
Min JH; Park DG; Yoon JH; An YS
Clin Nucl Med; 2019 Jan; 44(1):e49-e50. PubMed ID: 30371594
[TBL] [Abstract][Full Text] [Related]
2. Comparison of perfusion 18F-FP-CIT PET and 99mTc-ECD SPECT in parkinsonian disorders.
Chun K; Kong E; Cho I
Medicine (Baltimore); 2021 Aug; 100(34):e27019. PubMed ID: 34449475
[TBL] [Abstract][Full Text] [Related]
3. Additional Value of Early-Phase 18F-FP-CIT PET Image for Differential Diagnosis of Atypical Parkinsonism.
Jin S; Oh M; Oh SJ; Oh JS; Lee SJ; Chung SJ; Kim JS
Clin Nucl Med; 2017 Feb; 42(2):e80-e87. PubMed ID: 27922865
[TBL] [Abstract][Full Text] [Related]
4. Dual-Phase 18 F-FP-CIT PET in 2 Different Clinical Phenotypes of Sporadic Creutzfeldt-Jakob Disease.
Lee K; Park DG; Kim MS; An YS; Yoon JH
Clin Nucl Med; 2022 Aug; 47(8):e548-e549. PubMed ID: 35439185
[TBL] [Abstract][Full Text] [Related]
5. The Role of Dual-Phase 18 F-FP-CIT PET to Early Diagnosis of Corticobasal Syndrome.
Kim MS; Park DG; Shin IJ; An YS; Yoon JH
Clin Nucl Med; 2024 Feb; 49(2):124-130. PubMed ID: 38015725
[TBL] [Abstract][Full Text] [Related]
6. Early perfusion and dopamine transporter imaging using
Hong CM; Ryu HS; Ahn BC
Am J Nucl Med Mol Imaging; 2018; 8(6):360-372. PubMed ID: 30697456
[TBL] [Abstract][Full Text] [Related]
7. Use of 11C-PE2I PET in differential diagnosis of parkinsonian disorders.
Appel L; Jonasson M; Danfors T; Nyholm D; Askmark H; Lubberink M; Sörensen J
J Nucl Med; 2015 Feb; 56(2):234-42. PubMed ID: 25593112
[TBL] [Abstract][Full Text] [Related]
8. An Incidental Finding of Skull Hemangioma During 18F-FP CIT Brain PET/CT.
Chun KA; Kong E; Cho I
Clin Nucl Med; 2015 Oct; 40(10):e488-9. PubMed ID: 26284761
[TBL] [Abstract][Full Text] [Related]
9. Dual-phase 18F-FP-CIT PET in corticobasal syndrome underlying AD pathology.
Yoon JH; Ahn YS
Eur J Nucl Med Mol Imaging; 2019 Sep; 46(10):2208-2209. PubMed ID: 31273435
[No Abstract] [Full Text] [Related]
10. Diagnostic accuracy of dual-phase
Oh M; Lee N; Kim C; Son HJ; Sung C; Oh SJ; Lee SJ; Chung SJ; Lee CS; Kim JS
Sci Rep; 2021 Jul; 11(1):14992. PubMed ID: 34294739
[TBL] [Abstract][Full Text] [Related]
11. Anaplastic Oligodendroglioma Found as an Incidental Photopenic Lesion on 18F-FP-CIT PET/CT Image.
An YS; Yoon JK; Lee SJ; Jeong E; Kim IH
Clin Nucl Med; 2019 Mar; 44(3):e168-e169. PubMed ID: 30672761
[TBL] [Abstract][Full Text] [Related]
12. Clinical features of drug-induced parkinsonism based on [18F] FP-CIT positron emission tomography.
Shin HW; Kim JS; Oh M; You S; Kim YJ; Kim J; Kim MJ; Chung SJ
Neurol Sci; 2015 Feb; 36(2):269-74. PubMed ID: 25231645
[TBL] [Abstract][Full Text] [Related]
13. Dopamine transporters, D2 receptors, and glucose metabolism in corticobasal degeneration.
Klaffke S; Kuhn AA; Plotkin M; Amthauer H; Harnack D; Felix R; Kupsch A
Mov Disord; 2006 Oct; 21(10):1724-7. PubMed ID: 16773621
[TBL] [Abstract][Full Text] [Related]
14. Differential Diagnosis of Parkinsonism Using Dual-Phase F-18 FP-CIT PET Imaging.
Jin S; Oh M; Oh SJ; Oh JS; Lee SJ; Chung SJ; Lee CS; Kim JS
Nucl Med Mol Imaging; 2013 Mar; 47(1):44-51. PubMed ID: 24895507
[TBL] [Abstract][Full Text] [Related]
15. Global scaling for semi-quantitative analysis in FP-CIT SPECT.
Kupitz D; Apostolova I; Lange C; Ulrich G; Amthauer H; Brenner W; Buchert R
Nuklearmedizin; 2014; 53(6):234-41. PubMed ID: 25209576
[TBL] [Abstract][Full Text] [Related]
16.
Chen P; Li J; Li Z; Yu D; Ma N; Xia Z; Meng X; Liu X
Ann Nucl Med; 2023 Apr; 37(4):219-226. PubMed ID: 36609801
[TBL] [Abstract][Full Text] [Related]
17. Spatial Normalization Using Early-Phase [
Bae S; Choi H; Whi W; Paeng JC; Cheon GJ; Kang KW; Lee DS
Nucl Med Mol Imaging; 2020 Dec; 54(6):305-314. PubMed ID: 33282002
[TBL] [Abstract][Full Text] [Related]
18. Segmentation-based MR attenuation correction including bones also affects quantitation in brain studies: an initial result of 18F-FP-CIT PET/MR for patients with parkinsonism.
Choi H; Cheon GJ; Kim HJ; Choi SH; Lee JS; Kim YI; Kang KW; Chung JK; Kim EE; Lee DS
J Nucl Med; 2014 Oct; 55(10):1617-22. PubMed ID: 25134529
[TBL] [Abstract][Full Text] [Related]
19. An FP-CIT PET comparison of the differences in dopaminergic neuronal loss between idiopathic Parkinson disease with dementia and without dementia.
Song IU; Kim YD; Cho HJ; Chung SW; Chung YA
Alzheimer Dis Assoc Disord; 2013; 27(1):51-5. PubMed ID: 22354157
[TBL] [Abstract][Full Text] [Related]
20. Precise Evaluation of Striatal Oxidative Stress Corrected for Severity of Dopaminergic Neuronal Degeneration in Patients with Parkinson's Disease: A Study with 62Cu-ATSM PET and 123I-FP-CIT SPECT.
Neishi H; Ikawa M; Okazawa H; Tsujikawa T; Arishima H; Kikuta KI; Yoneda M
Eur Neurol; 2017; 78(3-4):161-168. PubMed ID: 28848099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
